Skip to main content
Midas Edge

MAXCYTE INC

For the period ended Mar 31, 2024. Filed May 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 7, 2024

MXCT$1.13-13.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Changes in Stockholders’ Equity

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity

(in thousands, except share amounts)

​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Total
​ · ​ · Common Stock · ​ · Additional · ​ · Accumulated · ​ · Stockholders’
​ · Shares · Amount · Paid-in Capital · Deficit · Equity
Balance at January 1, 2023102,397,913​$1,024​$390,819​$(137,875)​$253,968
Stock-based compensation expense—​—​3,277​—​3,277
Exercise of stock options​506,832​​5​​1,451​​—​​1,456
Net loss—​—​—​(10,882)​(10,882)
Balance at March 31, 2023102,904,745​$1,029​$395,547​$(148,757)​$247,819
​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Total
​ · ​ · Common Stock · ​ · Additional · ​ · Accumulated · ​ · Stockholders’
​ · Shares · Amount · Paid-in Capital · Deficit · Equity
Balance at January 1, 2024103,961,670​$1,040​$406,925​$(175,798)​$232,167
Stock-based compensation expense—​—​3,015​—​3,015
Exercise of stock options​272,640​​3​​700​​—​​703
Vesting of restricted stock units​170,801​​1​​(1)​​—​​—
Net loss—​—​—​(9,526)​(9,526)
Balance at March 31, 2024104,405,111​$1,044​$410,639​$(185,324)​$226,359
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.